Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

SELL
$28.79 - $35.41 $3,569 - $4,390
-124 Reduced 87.32%
18 $0
Q2 2022

Aug 12, 2022

BUY
$25.33 - $34.25 $1,494 - $2,020
59 Added 71.08%
142 $4,000
Q1 2022

May 13, 2022

SELL
$28.51 - $32.9 $7,070 - $8,159
-248 Reduced 74.92%
83 $2,000
Q4 2021

Feb 14, 2022

BUY
$26.37 - $34.22 $8,728 - $11,326
331 New
331 $9,000
Q4 2020

Feb 12, 2021

SELL
$17.7 - $25.81 $5,575 - $8,130
-315 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$20.2 - $25.05 $1,292 - $1,603
64 Added 25.5%
315 $6,000
Q2 2020

Aug 12, 2020

SELL
$17.09 - $24.89 $3,452 - $5,027
-202 Reduced 44.59%
251 $6,000
Q1 2020

May 12, 2020

BUY
$14.45 - $24.69 $4,667 - $7,974
323 Added 248.46%
453 $8,000
Q4 2019

Feb 07, 2020

SELL
$19.93 - $29.13 $23,178 - $33,878
-1,163 Reduced 89.95%
130 $3,000
Q3 2019

Nov 12, 2019

SELL
$25.47 - $33.37 $764 - $1,001
-30 Reduced 2.27%
1,293 $36,000
Q2 2019

Aug 09, 2019

BUY
$29.96 - $38.87 $7,220 - $9,367
241 Added 22.27%
1,323 $44,000
Q1 2019

May 10, 2019

BUY
$32.77 - $41.99 $24,806 - $31,786
757 Added 232.92%
1,082 $38,000
Q2 2018

Jul 31, 2018

BUY
$44.1 - $59.85 $14,332 - $19,451
325 New
325 $19,000

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.06B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.